Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies

Clinical trial NCT07312630 · RECRUITING

Trial details

NCT number: NCT07312630
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma (NHL)Acute Lymphoblastic Leukemia (ALL), Adult

Start date: 2025-09-25
Primary completion: 2026-09-25
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.